Canada halts AstraZeneca COVID-19 vaccine for people 55 and under, citing 'uncertainty' on blood clots


Canada's 13 provinces and territories, on advice from the National Advisory Committee on Immunization, suspended use of AstraZeneca's vaccine on people 55 and younger Monday. The advisory committee said its recommendation was a "precautionary measure" due to "rare" cases of blood clots in Europe, mostly affecting women under 55. "There is substantial uncertainty about the benefit of providing AstraZeneca COVID-19 vaccines to adults under 55 given the potential risks," said Dr. Shelley Deeks, the committee's vice chair.
AstraZeneca is a relatively small part of Canada's COVID-19 vaccine strategy, but it is hugely important for the global vaccination effort and is widely used in Britain. Europe's drug regulator said there is no evidence of an overall increase in blood clots and the vaccine is safe and effective to use. Canadian officials said they want more information about the blood clots, especially in young women. There have been no reports of blood clots in Canada, and the country is still using the vaccine for those over 55.
AstraZeneca's "vaccine has had all the ups and downs," Dr. Caroline Quach-Thanh, chair of the National Advisory Committee on Immunization, told reporters Monday. "It looks like a roller coaster." Canada approved the vaccine, developed by Oxford University, in late February, but only for people under 65. When British data came in showing its effectiveness on older people, Canada reversed itself. Now it has changed its advice again.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The messaging has been brutal overall," Dr. Andrew Morris, a professor of infectious diseases at the University of Toronto, tells The Associated Press. "I am fearful it is toast. It shouldn't be."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Jared and Ivanka's Albanian island
Under The Radar The deal to develop Sazan has been met with widespread opposition
-
Storm warning
Feature The U.S. is headed for an intense hurricane season. Will a shrunken FEMA and NOAA be able to respond?
-
U.S. v. Skrmetti: Did the trans rights movement overreach?
Feature The Supreme Court upholds a Tennessee law that bans transgender care for minors, dealing a blow to trans rights
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year
-
Economists fear US inflation data less reliable
speed read The Labor Department is collecting less data for its consumer price index due to staffing shortages
-
Crypto firm Coinbase hacked, faces SEC scrutiny
Speed Read The Securities and Exchange Commission has also been investigating whether Coinbase misstated its user numbers in past disclosures
-
Starbucks baristas strike over dress code
speed read The new uniform 'puts the burden on baristas' to buy new clothes, said a Starbucks Workers United union delegate
-
Warren Buffet announces surprise retirement
speed read At the annual meeting of Berkshire Hathaway, the billionaire investor named Vice Chairman Greg Abel his replacement
-
Trump calls Amazon's Bezos over tariff display
Speed Read The president was not happy with reports that Amazon would list the added cost from tariffs alongside product prices
-
Markets notch worst quarter in years as new tariffs loom
Speed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
-
Tesla Cybertrucks recalled over dislodging panels
Speed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off